Back to Results
First PageMeta Content
Cutaneous T-cell lymphoma / B-cell chronic lymphocytic leukemia / Peripheral T-cell lymphoma-Not-Otherwise-Specified / Mantle cell lymphoma / Lymphoma / Medicine / Oncology


Award ID: CP130023 Project Title: Novel Ceramide-modulating Therapeutics for Cancer Use Award Mechanism: Company Formation
Add to Reading List

Document Date: 2015-03-24 12:30:06

Open Document

File Size: 45,15 KB

Share Result on Facebook

Company

CerRx Inc. / /

Event

FDA Phase / /

IndustryTerm

Therapeutics for Cancer / /

MedicalCondition

advanced Peripheral T-cell lymphoma / cancers / relapsed lymphomas / advanced solid tumors / cancer / T-cell lymphoma / colon and small cell lung cancer / advanced Cutaneous T-cell lymphoma / /

Organization

FDA / CPRIT mission / /

Position

Company Formation Principal Investigator / /

Product

T-cell / /

ProvinceOrState

Texas / /

SocialTag